Mealey's (February 23, 2018, 8:22 AM EST) -- NEWARK, N.J. — A trade secret will not be stricken in a misappropriation of trade secrets lawsuit because a pharmaceutical company’s exclusion of evidence for the trade secret was not done with willful deception or in “flagrant disregard of a court order by the proponent of the evidence,” a federal judge in New Jersey ruled Feb. 8 in denying a motion by defendants to strike the trade secret (Par Pharmaceutical Inc., et al. v. QuVa Pharma Inc., et al., No. 17-6115, D. N.J., 2015 U.S. Dist. LEXIS 20775)....